Clinical Trial: Assessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Healthy Individuals H

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804485) titled 'Assessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Healthy Individuals H' on Aug. 17.

Brief Summary: To study the effect of relocation from high altitude (Quito Ecuador: 2850m) to sea level on pulmonary resistance (sPAP/CO) and other hemodynamic outcomes in healthy individuals, who live permanently >2600m.

Study Start Date: Sept. 25

Study Type: INTERVENTIONAL

Condition: High Altitude Healthy Adult Echocardiography Pulmonary Resistance Hemodynamic Changes Healthy

Intervention: BEHAVIORAL: Descent from 2850m to sea level

Descent from 2850m to sea level with a stay for 7 days

Recruitme...